• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Factors associated with blood loss in ankylosing spondylitis patients with hip involvement undergoing primary total hip arthroplasty: a cross-sectional retrospective study of 243 patients.与原发性全髋关节置换术治疗髋关节受累的强直性脊柱炎患者失血相关的因素:243 例患者的横断面回顾性研究。
J Orthop Surg Res. 2020 Nov 18;15(1):541. doi: 10.1186/s13018-020-02064-z.
2
Clinical Efficacy of Intra-articular Tranexamic Acid Injection in the Management of Hemophilia with Total Hip Arthroplasty: A 24-month Retrospective Cohort Study.关节内注射氨甲环酸治疗全髋关节置换术后血友病的临床疗效:一项 24 个月的回顾性队列研究。
Orthop Surg. 2024 Jul;16(7):1673-1683. doi: 10.1111/os.14126. Epub 2024 Jun 3.
3
Predisposing factors for allogeneic blood transfusion in patients with ankylosing spondylitis undergoing primary unilateral total hip arthroplasty: a retrospective study.在接受初次单侧全髋关节置换术的强直性脊柱炎患者中,异体输血的易患因素:一项回顾性研究。
J Orthop Surg Res. 2023 Jan 4;18(1):9. doi: 10.1186/s13018-022-03464-z.
4
Tranexamic acid may benefit patients undergoing total hip/knee arthroplasty because of haemophilia.氨甲环酸可能对患有血友病的髋关节/膝关节置换术患者有益。
BMC Musculoskelet Disord. 2019 Sep 4;20(1):402. doi: 10.1186/s12891-019-2767-x.
5
Active ankylosing spondylitis increases blood loss during total hip arthroplasty for a stiff hip joint.活动期强直性脊柱炎会增加僵硬髋关节行全髋关节置换术时的出血量。
BMC Musculoskelet Disord. 2020 Apr 15;21(1):243. doi: 10.1186/s12891-020-03278-2.
6
Predictors of perioperative blood loss in total joint arthroplasty.全关节置换术围手术期出血的预测因素。
J Bone Joint Surg Am. 2013 Oct 2;95(19):1777-83. doi: 10.2106/JBJS.L.01335.
7
One Dose of Intravenous Tranexamic Acid Is Equivalent to Two Doses in Total Hip and Knee Arthroplasty.静脉注射氨甲环酸一剂的效果等同于全髋关节和膝关节置换术两剂的效果。
J Bone Joint Surg Am. 2018 Jul 5;100(13):1104-1109. doi: 10.2106/JBJS.17.00641.
8
Intravenous Combined with Topical Administration of Tranexamic Acid in Primary Total Hip Arthroplasty: A Randomized Controlled Trial.静脉联合局部应用氨甲环酸在初次全髋关节置换术中的随机对照试验
Orthop Surg. 2017 May;9(2):174-179. doi: 10.1111/os.12287. Epub 2017 Jan 17.
9
[Local Application of Tranexamic Acid in Total Hip Arthroplasty Decreases Blood Loss and Consumption of Blood Transfusion].氨甲环酸局部应用于全髋关节置换术可减少失血及输血用量
Acta Chir Orthop Traumatol Cech. 2017;84(4):254-262.
10
[Mid-term results of total hip arthroplasty for treatment of ankylosing spondylitis].[全髋关节置换术治疗强直性脊柱炎的中期结果]
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2014 Jan;28(1):1-6.

引用本文的文献

1
Risk factors for perioperative blood transfusion in total hip arthroplasty: a meta-analysis.全髋关节置换术中围手术期输血的危险因素:一项荟萃分析。
BMC Musculoskelet Disord. 2025 Jun 7;26(1):569. doi: 10.1186/s12891-025-08801-x.
2
Postoperative complications rates and outcomes following total hip arthroplasty in patients with ankylosing spondylitis: A systematic review.强直性脊柱炎患者全髋关节置换术后的并发症发生率及预后:一项系统评价
J Orthop. 2025 Mar 17;69:86-95. doi: 10.1016/j.jor.2025.03.037. eCollection 2025 Nov.
3
Bony ankylosis adversely affects postoperative hip function in patients with ankylosing spondylitis undergoing total hip arthroplasty: a retrospective cohort study of 319 consecutive patients.骨融合对强直性脊柱炎患者全髋关节置换术后的髋关节功能产生不利影响:一项对319例连续患者的回顾性队列研究。
BMC Musculoskelet Disord. 2025 Feb 5;26(1):121. doi: 10.1186/s12891-025-08369-6.
4
Risk factor analysis and establishment of a nomogram model to predict blood loss during total knee arthroplasty.风险因素分析及建立全膝关节置换术失血量预测列线图模型。
BMC Musculoskelet Disord. 2024 Jun 10;25(1):459. doi: 10.1186/s12891-024-07570-3.
5
Predisposing factors for allogeneic blood transfusion in patients with ankylosing spondylitis undergoing primary unilateral total hip arthroplasty: a retrospective study.在接受初次单侧全髋关节置换术的强直性脊柱炎患者中,异体输血的易患因素:一项回顾性研究。
J Orthop Surg Res. 2023 Jan 4;18(1):9. doi: 10.1186/s13018-022-03464-z.
6
Early Clinical and Radiographic Outcomes of Robot-Assisted Versus Conventional Manual Total Knee Arthroplasty: A Randomized Controlled Study.机器人辅助与传统手动全膝关节置换术的早期临床和影像学结果:一项随机对照研究。
Orthop Surg. 2022 Sep;14(9):1972-1980. doi: 10.1111/os.13323. Epub 2022 Jul 18.
7
Transcriptome-Wide Association Studies and Integration Analysis of mRNA Expression Profiles Identify Candidate Genes and Pathways Associated With Ankylosing Spondylitis.全转录组关联研究和 mRNA 表达谱的整合分析鉴定与强直性脊柱炎相关的候选基因和通路。
Front Immunol. 2022 May 10;13:814303. doi: 10.3389/fimmu.2022.814303. eCollection 2022.
8
Emerging Roles of Long Non-Coding RNAs in Ankylosing Spondylitis.长链非编码 RNA 在强直性脊柱炎中的新兴作用。
Front Immunol. 2022 Feb 10;13:790924. doi: 10.3389/fimmu.2022.790924. eCollection 2022.

本文引用的文献

1
Active ankylosing spondylitis increases blood loss during total hip arthroplasty for a stiff hip joint.活动期强直性脊柱炎会增加僵硬髋关节行全髋关节置换术时的出血量。
BMC Musculoskelet Disord. 2020 Apr 15;21(1):243. doi: 10.1186/s12891-020-03278-2.
2
Revisiting the International Normalized Ratio Threshold for Bleeding Risk and Mortality in Primary Total Hip Arthroplasty: A National Surgical Quality Improvement Program Analysis of 17,567 Patients.重新审视初次全髋关节置换术出血风险和死亡率的国际标准化比值阈值:一项针对 17567 例患者的国家手术质量改进计划分析。
J Bone Joint Surg Am. 2020 Jan 2;102(1):52-59. doi: 10.2106/JBJS.19.00160.
3
Tranexamic Acid Administration Is Not Associated With an Increase in Complications in High-Risk Patients Undergoing Primary Total Knee or Total Hip Arthroplasty: A Retrospective Case-Control Study of 38,220 Patients.氨甲环酸给药与初次全膝关节或全髋关节置换术高风险患者并发症的增加无关:一项回顾性病例对照研究,纳入了 38220 例患者。
J Arthroplasty. 2020 Jan;35(1):45-51.e3. doi: 10.1016/j.arth.2019.08.015. Epub 2019 Aug 17.
4
The effects of total hip arthroplasty in treating hip bony fusion in young and middle-aged patients with ankylosing spondylitis.全髋关节置换术治疗中青年强直性脊柱炎髋关节骨融合的疗效。
J Orthop Surg Res. 2019 Aug 8;14(1):253. doi: 10.1186/s13018-019-1288-5.
5
Bilaterally Primary Cementless Total Hip Arthroplasty for Severe Hip Ankylosis with Ankylosing Spondylitis.双侧初次非骨水泥型全髋关节置换术治疗强直性脊柱炎所致严重髋关节强直
Orthop Surg. 2016 Aug;8(3):352-9. doi: 10.1111/os.12254.
6
Chemical Thromboprophylaxis Is Not Necessary to Reduce Risk of Thromboembolism With Tranexamic Acid After Total Hip Arthroplasty.全髋关节置换术后使用氨甲环酸时,化学性血栓预防对于降低血栓栓塞风险并非必要。
J Arthroplasty. 2017 Feb;32(2):641-644. doi: 10.1016/j.arth.2016.07.048. Epub 2016 Aug 11.
7
Tranexamic Acid Administration in Primary Total Hip Arthroplasty: A Randomized Controlled Trial of Intravenous Combined with Topical Versus Single-Dose Intravenous Administration.氨甲环酸在初次全髋关节置换术中的应用:静脉联合局部与单次静脉给药的随机对照试验。
J Bone Joint Surg Am. 2016 Jun 15;98(12):983-91. doi: 10.2106/JBJS.15.00638.
8
Comparison of Blood Loss After Total Hip Arthroplasty Between Ankylosing Spondylitis and Osteoarthritis.强直性脊柱炎与骨关节炎患者全髋关节置换术后失血情况的比较。
J Arthroplasty. 2016 Jul;31(7):1504-9. doi: 10.1016/j.arth.2015.12.049. Epub 2016 Feb 27.
9
Early-stage hip involvement in patients with ankylosing spondylitis: A Chinese study based on magnetic resonance imaging.早期髋关节受累的强直性脊柱炎患者:一项基于磁共振成像的中国研究。
Mod Rheumatol. 2016 Nov;26(6):933-939. doi: 10.3109/14397595.2016.1153232. Epub 2016 Mar 4.
10
Does tranexamic acid alter the risk of thromboembolism after total hip arthroplasty in the absence of routine chemical thromboprophylaxis?在未进行常规化学性血栓预防的情况下,氨甲环酸会改变全髋关节置换术后血栓栓塞的风险吗?
Bone Joint J. 2015 Apr;97-B(4):458-62. doi: 10.1302/0301-620X.97B4.34656.

与原发性全髋关节置换术治疗髋关节受累的强直性脊柱炎患者失血相关的因素:243 例患者的横断面回顾性研究。

Factors associated with blood loss in ankylosing spondylitis patients with hip involvement undergoing primary total hip arthroplasty: a cross-sectional retrospective study of 243 patients.

机构信息

Medical School of Chinese PLA, Beijing, China.

Department of Orthopaedics, The First Medical Centre, Chinese PLA General Hospital, Beijing, China.

出版信息

J Orthop Surg Res. 2020 Nov 18;15(1):541. doi: 10.1186/s13018-020-02064-z.

DOI:10.1186/s13018-020-02064-z
PMID:33208176
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7672842/
Abstract

BACKGROUND

Total hip arthroplasty (THA) can cause considerable blood loss and perioperative transfusion in ankylosing spondylitis (AS) patients. This study aimed to identify the factors related to blood loss in AS patients with hip involvement undergoing THA.

METHODS

We analyzed 243 AS patients with advanced hip involvement undergoing primary THA from 2012 to 2017. Bilateral THA was performed by a one-stage operation during one general anesthesia session. The patients were divided into three groups according to the grade of blood loss, as determined by the Advanced Trauma Life Support hypovolemic shock classification system. Ordinal logistic regression was used to identify factors associated with blood loss in the patients.

RESULTS

The proportion of patients who were male, underwent bilateral THA, had a hip range of motion (ROM) = 0°, had a BASRI-hip score of 4, underwent iliopsoas and adductor release, and underwent autologous or allogenic transfusion increased significantly with the grade of blood loss, while that of the patients who received tranexamic acid (TXA) decreased significantly (P < 0.05). The preoperative hemoglobin (Hb) level, hematocrit level, and operating time also increased significantly with the grade of blood loss (P < 0.05). The ordinal logistic regression results identified the factors related to blood loss during THA in AS patients with hip involvement to be the male sex (odds ratio [OR] = 3.287; 95% confidence interval [CI] 1.022, 10.567), bilateral THA (OR = 13.896; 95% CI 4.950, 39.011), hip ROM = 0° (OR = 2.513; 95% CI 1.277, 4.946), an elevated erythrocyte sedimentation rate (ESR) level (OR = 3.042; 95% CI 1.320, 7.014), an elevated preoperative Hb level (OR = 1.043; 95% CI 1.017, 1.070), a long operating time (OR = 1.009; 95% CI 1.003, 1.016), and the administration of TXA (OR = 0.252; 95% CI 0.134, 0.472).

CONCLUSIONS

The male sex, bilateral THA, a hip ROM = 0°, an elevated ESR level, a high preoperative Hb level, and a long operating time are risk factors associated with blood loss in AS patients with hip involvement undergoing THA, while the administration of TXA is a protective factor. These results might help determine the risk of bleeding in the perioperative assessment and develop more efficient blood management strategies for THA in AS patients with hip involvement.

摘要

背景

全髋关节置换术(THA)可导致强直性脊柱炎(AS)患者大量失血和围手术期输血。本研究旨在确定髋关节受累行 THA 的 AS 患者失血相关的因素。

方法

我们分析了 2012 年至 2017 年期间 243 例髋关节受累接受初次 THA 的 AS 患者。双侧 THA 在一次全身麻醉过程中通过一次手术进行。根据高级创伤生命支持低血容量性休克分类系统确定失血量,将患者分为三组。使用有序逻辑回归确定与患者失血相关的因素。

结果

男性、双侧 THA、髋关节活动度(ROM)= 0°、BASRI-髋关节评分 4 分、行髂腰肌和内收肌松解、接受自体或同种异体输血的患者比例随着失血量的增加而显著增加,而接受氨甲环酸(TXA)的患者比例则显著降低(P < 0.05)。术前血红蛋白(Hb)水平、血细胞比容水平和手术时间也随失血量的增加而显著增加(P < 0.05)。有序逻辑回归结果确定了与髋关节受累的 AS 患者 THA 期间失血相关的因素为男性(比值比[OR] = 3.287;95%置信区间[CI] 1.022,10.567)、双侧 THA(OR = 13.896;95% CI 4.950,39.011)、髋关节 ROM = 0°(OR = 2.513;95% CI 1.277,4.946)、红细胞沉降率(ESR)升高(OR = 3.042;95% CI 1.320,7.014)、术前 Hb 水平升高(OR = 1.043;95% CI 1.017,1.070)、手术时间长(OR = 1.009;95% CI 1.003,1.016)和 TXA 给药(OR = 0.252;95% CI 0.134,0.472)。

结论

男性、双侧 THA、髋关节 ROM = 0°、ESR 升高、术前 Hb 水平升高和手术时间长是髋关节受累的 AS 患者 THA 失血的相关危险因素,而 TXA 给药是保护因素。这些结果可能有助于确定围手术期出血风险,并为髋关节受累的 AS 患者制定更有效的血液管理策略。